Total Funding
94
90
Total FundingVenture - Series Unknown raised
Growth Score 94 in past quarter
4 pts
Heat Score 90 in past quarter
81 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
60700
HEM Pharma is a microbiome biotechnology company that supports microbiome solutions and functional nutrition products.
- Ji Yo-seop: Co-founder and CEO
- Wilhelm Holzapfel: Co-founder and CTOPast Role: International Union of Microbiological Societies, President
About the Company
HEM Pharma is a biotechnology firm that focuses on personalized microbiome healthcare, live biotherapeutic drug (LBP) development, microbiome analysis, and health-functional food manufacturing. The company leverages proprietary microbiome technologies to develop individualized health solutions and next-generation microbiome-based therapeutics. and
supporting personalized microbiome solutions and functional nutrition products. HEM Pharma has expanded internationally through its Japanese subsidiary and global research partnerships.